The Heart and Vascular Team: Time for Endocrinologists to Join the Club?

Affiliations

¹ Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado; University of Colorado School of Medicine, Aurora, Colorado. Electronic address: ehrin.armstrong@gmail.com.
² Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado; University of Colorado School of Medicine, Aurora, Colorado.

Free article

Editorial

Ehrin J Armstrong et al. J Am Coll Cardiol. 2018.

Free article

. 2018 Dec 25;72(25):3285-3286.

doi: 10.1016/j.jacc.2018.10.032.

¹ Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado; University of Colorado School of Medicine, Aurora, Colorado. Electronic address: ehrin.armstrong@gmail.com.
² Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado; University of Colorado School of Medicine, Aurora, Colorado.

No abstract available

Keywords: P2Y(12) inhibitor; antithrombotic; cardiovascular; diabetes; limb amputation; peripheral artery disease.

Comment on

Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial.
Low Wang CC, Blomster JI, Heizer G, Berger JS, Baumgartner I, Fowkes FGR, Held P, Katona BG, Norgren L, Jones WS, Lopes RD, Olin JW, Rockhold FW, Mahaffey KW, Patel MR, Hiatt WR; EUCLID Trial Executive Committee and Investigators. Low Wang CC, et al. J Am Coll Cardiol. 2018 Dec 25;72(25):3274-3284. doi: 10.1016/j.jacc.2018.09.078. J Am Coll Cardiol. 2018. PMID: 30573030 Clinical Trial.